An Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With Schizophrenia
Clinical trial NCT00269919 · COMPLETED
Trial details
- NCT number
- NCT00269919
- Sponsor
- Janssen Korea, Ltd., Korea
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2008-08-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.